Japan approves Somatuline from Ipsen and Teijin for GEP-NETs

Ipsen Group (Euronext:IPN; Pink:IPSEY) and Teijin Pharma Ltd. (Tokyo, Japan) said Japan approved Somatuline Autogel lanreotide acetate (ITM-014) to treat gastroenteropancreatic neuroendocrine tumors...